ISIN | LU0396226531 |
---|---|
Valor Number | 4761030 |
Bloomberg Global ID | BBG000MCQCZ5 |
Fund Name | Europe Index -R dy GBP |
Fund Provider |
Pictet Asset Management S.A.
Genève, Switzerland Phone: +41 58 323 10 24 www.assetmanagement.pictet |
Fund Provider | Pictet Asset Management S.A. |
Representative in Switzerland |
Pictet Asset Management S.A. Genève 73 Phone: +41 58 323 30 00 |
Distributor(s) |
Credit Suisse AG Zürich Phone: +41 44 333 11 11 UBS AG Zürich Phone: +41 44 234 11 11 Vontobel Fonds Services AG Zürich Phone: +41 58 283 74 77 |
Asset Class | Equities |
EFC Category | Equity Advanced Europe |
Distribution Policy | Distribution |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The investment objective of the fund is to achieve a performance comparable to the reference index. The Fund aims for the full physical replication of the MSCI Europe Index (the “Benchmark Index”). |
Peculiarities |
Current Price * | 179.70 GBP | 02.07.2025 |
---|---|---|
Previous Price * | 177.84 GBP | 01.07.2025 |
52 Week High * | 179.73 GBP | 12.06.2025 |
52 Week Low * | 154.05 GBP | 07.04.2025 |
NAV * | 179.70 GBP | 02.07.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 1,051,724,245 | |
Unit/Share Assets *** | 358,430 | |
Trading Information SIX |
YTD Performance | +13.78% |
31.12.2024 - 02.07.2025
31.12.2024 02.07.2025 |
---|---|---|
YTD Performance (in CHF) | +8.36% |
31.12.2024 - 02.07.2025
31.12.2024 02.07.2025 |
1 month | +1.39% |
02.06.2025 - 02.07.2025
02.06.2025 02.07.2025 |
3 months | +5.42% |
02.04.2025 - 02.07.2025
02.04.2025 02.07.2025 |
6 months | +13.00% |
03.01.2025 - 02.07.2025
03.01.2025 02.07.2025 |
1 year | +8.04% |
02.07.2024 - 02.07.2025
02.07.2024 02.07.2025 |
2 years | +17.59% |
03.07.2023 - 02.07.2025
03.07.2023 02.07.2025 |
3 years | +33.09% |
04.07.2022 - 02.07.2025
04.07.2022 02.07.2025 |
5 years | +43.91% |
02.07.2020 - 02.07.2025
02.07.2020 02.07.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
SAP SE | 2.56% | |
---|---|---|
ASML Holding NV | 2.37% | |
Nestle SA | 2.27% | |
Roche Holding AG | 1.84% | |
AstraZeneca PLC | 1.81% | |
Novo Nordisk AS Class B | 1.81% | |
Novartis AG Registered Shares | 1.77% | |
HSBC Holdings PLC | 1.69% | |
Shell PLC | 1.61% | |
Siemens AG | 1.49% | |
Last data update | 31.05.2025 |
TER *** | 0.75% |
---|---|
TER date *** | 31.03.2025 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.90% |
Ongoing Charges *** | 0.76% |
SRRI ***
|
|
SRRI date *** | 30.06.2025 |